Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood flow measurement during distraction osteogenesis

K Minematsu1, H Tsuchiya, J Taki

  • 1Department of Orthopedic Surgery, School of Medicine, Kanazawa University, Japan.

Clinical Orthopaedics and Related Research
|April 1, 1998
PubMed
Summary

Distraction osteogenesis can maintain normal or increased regional blood flow, even during chemotherapy. This bone-lengthening technique may counteract chemotherapy

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world evidence of chemotherapy effects in advanced pancreatic ductal adenocarcinoma: prognostic significance of <i>TP53</i> status in gemcitabine plus nab-paclitaxel therapy.

ESMO gastrointestinal oncology·2026
Same author

Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease.

Scandinavian journal of rheumatology·2024
Same author

Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment.

Scandinavian journal of rheumatology·2023
Same author

Efficacy and safety of plasma exchange in interstitial lung diseases with anti-melanoma differentiation-associated 5 gene antibody positive clinically amyopathic dermatomyositis.

Scandinavian journal of rheumatology·2021
Same author

Orbital apex syndrome on initial presentation of giant cell arteritis: a case report and review of the literature.

Scandinavian journal of rheumatology·2021
Same author

Gamma-Ray Observation of the Cygnus Region in the 100-TeV Energy Region.

Physical review letters·2021

Area of Science:

  • Orthopedics
  • Oncology
  • Nuclear Medicine

Background:

  • Distraction osteogenesis is a surgical procedure to lengthen bones.
  • Chemotherapy can negatively impact regional blood flow, potentially affecting bone healing.
  • Understanding blood flow dynamics during distraction osteogenesis in tumor patients is crucial.

Purpose of the Study:

  • To evaluate regional blood flow during distraction osteogenesis in patients with and without tumors.
  • To assess the impact of chemotherapy on regional blood flow in distraction osteogenesis.
  • To determine if distraction osteogenesis can overcome chemotherapy-induced reductions in blood flow.

Main Methods:

  • Quantitative technetium scintigraphy was used to measure regional blood flow in 30 distraction segments across 27 patients.

Related Experiment Videos

  • Patients were divided into three groups: high-grade tumors with chemotherapy (Group A), low-grade/aggressive benign tumors without chemotherapy (Group B), and non-tumoral controls (Group C).
  • Blood flow was expressed as a ratio of the distracted site to a control site.

    • Main Results:

    • The overall average blood flow ratio was 1.70 +/- 0.70.
    • Group A (chemotherapy) showed a statistically significant lower blood flow ratio compared to Groups B and C.
    • No significant difference in callus formation was observed among the groups based on the external fixation index, and no correlation was found between blood flow ratio and external fixation index.

    Conclusions:

    • Chemotherapy significantly decreases regional blood flow.
    • Distraction osteogenesis can maintain or increase regional blood flow, potentially mitigating chemotherapy's negative effects.
    • Distraction osteogenesis may be a viable strategy to preserve or enhance blood flow in patients undergoing chemotherapy for bone tumors.